Swan Defence and Heavy Industries Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: August 21, 2025, 2:02 pm

Quick Insight

Reliance Naval & Engineering Ltd's current market dynamics indicate a precarious situation with a share price of 2.30 and a market capitalization of 170 Cr., coupled with negative profitability reflected in a Net Profit of -2,086 Cr. Furthermore, the company's high borrowing level of ₹2,361 Cr. and negative Price-to-Book Value (P/BV) ratio of -0.01x raise concerns about its financial health and ability to generate shareholder value. With Promoters not disclosed and limited institutional ownership, the company's future prospects seem uncertain. Investors should exercise caution due to the high financial leverage and negative performance indicators, indicating potential risks associated with investing in Reliance Naval & Engineering Ltd.

Competitors of Swan Defence and Heavy Industries Ltd

All Competitor Stocks of Swan Defence and Heavy Industries Ltd

Quarterly Result

Last Updated: August 21, 2025, 2:02 pm

Below is a detailed analysis of the quarterly data for Swan Defence and Heavy Industries Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 0.00 Cr.. The value appears to be declining and may need further review. It has decreased from 5.00 Cr. (Mar 2025) to 0.00 Cr., marking a decrease of 5.00 Cr..
• For Expenses, as of Jun 2025, the value is 32.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 14.00 Cr. (Mar 2025) to 32.00 Cr., marking an increase of 18.00 Cr..
• For Operating Profit, as of Jun 2025, the value is -32.00 Cr.. The value appears to be declining and may need further review. It has decreased from -9.00 Cr. (Mar 2025) to -32.00 Cr., marking a decrease of 23.00 Cr..
• For OPM %, as of Jun 2025, the value is -7,529.00%. The value appears to be declining and may need further review. It has decreased from -192.00% (Mar 2025) to -7,529.00%, marking a decrease of 7,337.00%.
• For Other Income, as of Jun 2025, the value is 18.00 Cr.. The value appears strong and on an upward trend. It has increased from 5.00 Cr. (Mar 2025) to 18.00 Cr., marking an increase of 13.00 Cr..
• For Interest, as of Jun 2025, the value is 2.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 2.00 Cr..
• For Depreciation, as of Jun 2025, the value is 15.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 16.00 Cr. (Mar 2025) to 15.00 Cr., marking a decrease of 1.00 Cr..
• For Profit before tax, as of Jun 2025, the value is -31.00 Cr.. The value appears to be declining and may need further review. It has decreased from -23.00 Cr. (Mar 2025) to -31.00 Cr., marking a decrease of 8.00 Cr..
• For Tax %, as of Jun 2025, the value is 0.00%. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00%.
• For Net Profit, as of Jun 2025, the value is -31.00 Cr.. The value appears to be declining and may need further review. It has decreased from -23.00 Cr. (Mar 2025) to -31.00 Cr., marking a decrease of 8.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is -5.92. The value appears to be declining and may need further review. It has decreased from -4.34 (Mar 2025) to -5.92, marking a decrease of 1.58.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: August 21, 2025, 2:02 pm

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: August 21, 2025, 2:02 pm

Below is a detailed analysis of the balance sheet data for Swan Defence and Heavy Industries Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 53.00 Cr.. The value appears strong and on an upward trend. It has increased from 3.00 Cr. (Mar 2024) to 53.00 Cr., marking an increase of 50.00 Cr..
• For Reserves, as of Mar 2025, the value is 243.00 Cr.. The value appears to be declining and may need further review. It has decreased from 474.00 Cr. (Mar 2024) to 243.00 Cr., marking a decrease of 231.00 Cr..
• For Borrowings, as of Mar 2025, the value is 2,505.00 Cr.. The value appears to be increasing, which may not be favorable. However, Borrowings exceed Reserves, which may signal higher financial risk. It has increased from 2,219.00 Cr. (Mar 2024) to 2,505.00 Cr., marking an increase of 286.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 91.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 48.00 Cr. (Mar 2024) to 91.00 Cr., marking an increase of 43.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 2,892.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2,743.00 Cr. (Mar 2024) to 2,892.00 Cr., marking an increase of 149.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 1,180.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,168.00 Cr. (Mar 2024) to 1,180.00 Cr., marking an increase of 12.00 Cr..
• For CWIP, as of Mar 2025, the value is 155.00 Cr.. The value appears strong and on an upward trend. It has increased from 43.00 Cr. (Mar 2024) to 155.00 Cr., marking an increase of 112.00 Cr..
• For Investments, as of Mar 2025, the value is 5.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 5.00 Cr..
• For Other Assets, as of Mar 2025, the value is 1,551.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,528.00 Cr. (Mar 2024) to 1,551.00 Cr., marking an increase of 23.00 Cr..
• For Total Assets, as of Mar 2025, the value is 2,892.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,743.00 Cr. (Mar 2024) to 2,892.00 Cr., marking an increase of 149.00 Cr..

However, the Borrowings (2,505.00 Cr.) are higher than the Reserves (243.00 Cr.), which may signal higher financial risk.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Swan Defence and Heavy Industries Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is -51.51. This value is below the healthy minimum of 5. It has decreased from -22.89 (Mar 24) to -51.51, marking a decrease of 28.62.
• For Diluted EPS (Rs.), as of Mar 25, the value is -51.51. This value is below the healthy minimum of 5. It has decreased from -22.89 (Mar 24) to -51.51, marking a decrease of 28.62.
• For Cash EPS (Rs.), as of Mar 25, the value is -22.90. This value is below the healthy minimum of 3. It has increased from -197.22 (Mar 24) to -22.90, marking an increase of 174.32.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 56.11. It has decreased from 1,590.67 (Mar 24) to 56.11, marking a decrease of 1,534.56.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 56.11. It has decreased from 1,590.67 (Mar 24) to 56.11, marking a decrease of 1,534.56.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 1.33. It has increased from 0.00 (Mar 24) to 1.33, marking an increase of 1.33.
• For PBDIT / Share (Rs.), as of Mar 25, the value is -18.50. This value is below the healthy minimum of 2. It has increased from -98.82 (Mar 24) to -18.50, marking an increase of 80.32.
• For PBIT / Share (Rs.), as of Mar 25, the value is -30.06. This value is below the healthy minimum of 0. It has increased from -354.07 (Mar 24) to -30.06, marking an increase of 324.01.
• For PBT / Share (Rs.), as of Mar 25, the value is -34.45. This value is below the healthy minimum of 0. It has increased from -452.46 (Mar 24) to -34.45, marking an increase of 418.01.
• For Net Profit / Share (Rs.), as of Mar 25, the value is -34.45. This value is below the healthy minimum of 2. It has increased from -452.46 (Mar 24) to -34.45, marking an increase of 418.01.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is -34.45. This value is below the healthy minimum of 2. It has increased from -449.61 (Mar 24) to -34.45, marking an increase of 415.16.
• For PBDIT Margin (%), as of Mar 25, the value is -1,386.34. This value is below the healthy minimum of 10. It has decreased from 0.00 (Mar 24) to -1,386.34, marking a decrease of 1,386.34.
• For PBIT Margin (%), as of Mar 25, the value is -2,252.34. This value is below the healthy minimum of 10. It has decreased from 0.00 (Mar 24) to -2,252.34, marking a decrease of 2,252.34.
• For PBT Margin (%), as of Mar 25, the value is -2,581.93. This value is below the healthy minimum of 10. It has decreased from 0.00 (Mar 24) to -2,581.93, marking a decrease of 2,581.93.
• For Net Profit Margin (%), as of Mar 25, the value is -2,581.93. This value is below the healthy minimum of 5. It has decreased from 0.00 (Mar 24) to -2,581.93, marking a decrease of 2,581.93.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is -2,581.93. This value is below the healthy minimum of 8. It has decreased from 0.00 (Mar 24) to -2,581.93, marking a decrease of 2,581.93.
• For Return on Networth / Equity (%), as of Mar 25, the value is -61.40. This value is below the healthy minimum of 15. It has decreased from -28.26 (Mar 24) to -61.40, marking a decrease of 33.14.
• For Return on Capital Employeed (%), as of Mar 25, the value is -6.09. This value is below the healthy minimum of 10. It has decreased from -4.36 (Mar 24) to -6.09, marking a decrease of 1.73.
• For Return On Assets (%), as of Mar 25, the value is -6.27. This value is below the healthy minimum of 5. It has decreased from -4.39 (Mar 24) to -6.27, marking a decrease of 1.88.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 7.59. This value exceeds the healthy maximum of 1. It has increased from 3.81 (Mar 24) to 7.59, marking an increase of 3.78.
• For Total Debt / Equity (X), as of Mar 25, the value is 8.23. This value exceeds the healthy maximum of 1. It has increased from 5.00 (Mar 24) to 8.23, marking an increase of 3.23.
• For Current Ratio (X), as of Mar 25, the value is 5.05. This value exceeds the healthy maximum of 3. It has increased from 2.53 (Mar 24) to 5.05, marking an increase of 2.52.
• For Quick Ratio (X), as of Mar 25, the value is 0.25. This value is below the healthy minimum of 1. It has increased from 0.05 (Mar 24) to 0.25, marking an increase of 0.20.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 4. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Interest Coverage Ratio (X), as of Mar 25, the value is -4.65. This value is below the healthy minimum of 3. It has decreased from -1.00 (Mar 24) to -4.65, marking a decrease of 3.65.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is -7.56. This value is below the healthy minimum of 3. It has decreased from -3.60 (Mar 24) to -7.56, marking a decrease of 3.96.
• For Enterprise Value (Cr.), as of Mar 25, the value is 2,881.43. It has increased from 2,116.14 (Mar 24) to 2,881.43, marking an increase of 765.29.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 409.88. This value exceeds the healthy maximum of 3. It has increased from 0.00 (Mar 24) to 409.88, marking an increase of 409.88.
• For EV / EBITDA (X), as of Mar 25, the value is -29.57. This value is below the healthy minimum of 5. It has increased from -79.84 (Mar 24) to -29.57, marking an increase of 50.27.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 68.01. This value exceeds the healthy maximum of 3. It has increased from 0.00 (Mar 24) to 68.01, marking an increase of 68.01.
• For Price / BV (X), as of Mar 25, the value is 1.62. This value is within the healthy range. It has increased from 0.00 (Mar 24) to 1.62, marking an increase of 1.62.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 68.04. This value exceeds the healthy maximum of 3. It has increased from 0.00 (Mar 24) to 68.04, marking an increase of 68.04.
• For EarningsYield, as of Mar 25, the value is -0.37. This value is below the healthy minimum of 5. It has increased from -198.07 (Mar 24) to -0.37, marking an increase of 197.70.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness